Autolus Therapeutics Reports Preliminary Second Quarter 2026 Net Product Revenue and Announces Credit Facility of up to $250 Million with Perceptive Advisors

Go back to Autolus Therapeutics Reports Preliminary Second Quarter 2026 Net Product Revenue and Announces Credit Facility of up to $250 Million with Perceptive Advisors
(NASDAQ: AUTL) Delayed: 2.24 -0.05 (2.18%)
Previous Close $2.29    52 Week High
Open $2.31    52 Week Low
Day High $2.31    P/E N/A 
Day Low $2.22    EPS
Volume 1,836,157